Plantone, Domenico https://orcid.org/0000-0001-6666-7244
Luigetti, Marco
Manco, Carlo
Romano, Angela
Leonardi, Luca
Guglielmino, Valeria
Forcina, Francesca
Ceccanti, Marco
Inghilleri, Maurizio
Manganelli, Fiore
Tozza, Stefano
Sciarrone, Maria Ausilia
Vitali, Francesca
Sabino, Andrea
Righi, Delia
Stufano, Angela
Stromillo, Maria Laura
De Stefano, Nicola
Calabresi, Paolo
Primiano, Guido
Funding for this research was provided by:
Ministero della Salute (GR-2021-12372306, GR-2021-12372306, GR-2021-12372306, GR-2021-12372306)
Università degli Studi di Siena
Article History
Received: 21 January 2025
Revised: 26 February 2025
Accepted: 26 March 2025
First Online: 15 April 2025
Declarations
:
: Marco Luigetti received financial grants (honoraria and speaking) from Ackea, Alnylam, AstraZeneca, Sobi, and Pfizer, and travel grants from Ackea, Alnylam, AstraZeneca, Sobi, Pfizer, Kedrion, and Grifols. Angela Romano received financial grants (honoraria and speaking) from Akcea, and travel grants to attend scientific meetings from Akcea, Alnylam, Pfizer, and Csl Behring. Fiore Manganelli received personal fees for scientific events from Alfa-Sigma, Alnylam Pharmaceuticals, and Akcea Therapeutics, and received a travel grant to attend scientific meetings from CSL Behring. Stefano Tozza received personal fees for scientific events from Alnylam Pharmaceuticals and Amicus Therapeutics, and travel grants to attend scientific meetings from Akcea Therapeutics. Maria Ausilia Sciarrone received travel grants to attend scientific meetings from Sobi. Francesca Vitali received travel grants to attend scientific meetings from Alnylam. All other authors declare that there are no disclosures.
: The study was approved by the local ethics committee of “Comitato Etico Territoriale Lazio Area 3” at the Fondazione Policlinico Agostino Gemelli IRCCS (protocol ID 5470), and all subjects provided written informed consent prior to participation in the study.